Analysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation
- PMID: 20603472
- DOI: 10.1001/archpediatrics.2010.110
Analysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation
Comment on
-
Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.Arch Pediatr Adolesc Med. 2010 Feb;164(2):116-23. doi: 10.1001/archpediatrics.2009.264. Arch Pediatr Adolesc Med. 2010. PMID: 20124139 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
